Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss.
Gür-Çetinkaya P, Çağdaş-Ayvaz DN, Öksüz AB, Ertoy A, Hayran U, Özkan F, Erol M, Tezcan İ.
Gür-Çetinkaya P, et al. Among authors: erol m.
Turk J Pediatr. 2018;60(3):270-276. doi: 10.24953/turkjped.2018.03.006.
Turk J Pediatr. 2018.
PMID: 30511539
Free article.
Gur-Cetinkaya P, Cagdas-Ayvaz DN, Oksuz AB, Ertoy A, Hayran U, Ozkan F, Erol M, Tezcan I. Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss. ...Serum immunoglobulin levels at t …
Gur-Cetinkaya P, Cagdas-Ayvaz DN, Oksuz AB, Ertoy A, Hayran U, Ozkan F, Erol M, Tezcan I. Advantage of the subcutaneous immuno …